Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma

Study on PEG-rhG-CSF for Preventing Neutropenia in Nasopharyngeal Carcinoma

Background

This study examines how effective and safe Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) is in preventing neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).

Methods

Conducted from June 1, 2021, to October 31, 2022, this single-center study involved patients with locally advanced NPC. Participants were split into two groups:

  • Experimental Group: Received PEG-rhG-CSF injections after chemotherapy cycles.
  • Control Group: Received standard care without additional treatment.

Key outcomes measured included:

  • Incidence of grade 3/4 neutropenia
  • Blood cell count changes
  • Rates of febrile neutropenia
  • Delays or interruptions in chemotherapy/radiotherapy
  • Incidents of oral mucositis and bone pain

Results

  • The experimental group had a lower incidence of grade 3 neutropenia (P = 0.026).
  • Higher white blood cell and neutrophil counts were observed in the experimental group (P < 0.01).
  • Delays in chemotherapy were significantly lower in the experimental group (2.3% vs. 29.5%, P = 0.001).
  • Radiotherapy interruptions were also lower in the experimental group (2.3% vs. 27.3%, P = 0.003).
  • 34.1% of patients in the experimental group experienced mild bone pain, with no severe cases reported.

Conclusions

Using PEG-rhG-CSF helps reduce neutropenia in patients undergoing concurrent chemoradiotherapy for NPC. This leads to fewer delays and interruptions in treatment, with manageable side effects.

Clinical Trials and Practical Solutions

Clinical trials are essential for developing safe and effective treatments. To make these benefits accessible, we offer DocSym, an AI-driven platform that combines ICD-11 standards, clinical protocols, and research into a single, user-friendly knowledge base for healthcare providers.

Streamlined Operations

In today’s healthcare landscape, efficiency is key. Our mobile apps facilitate:

  • Scheduling and monitoring treatments
  • Telemedicine services

This enhances patient care management and expands digital services.

Enhanced Workflows

By leveraging AI, clinics can optimize workflows, improve patient outcomes, and reduce reliance on paper processes. Discover more about our solutions at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.